Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukta Sharma

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
American Journal of Hematology|May 19, 2020
Laboratory misdiagnosis of von Willebrand disease in post-menarchal females: A multi-center studyJulie Jaffray, Janice M Staber, Jemily Malvar, et al.
Blood|August 19, 2011
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971Alan S Gamis, Todd A Alonzo, Robert B Gerbing, et al.
Stroke|April 23, 2019
Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke ManagementKristin P Guilliams, Fenella J Kirkham, Susanne Holzhauer, et al.
Blood Advances|September 1, 2021
Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiencyHanny Al-Samkari, Eduard J van Beers, D Holmes Morton, et al.
Clinical Epidemiology|June 2, 2026
Real-World Incidence and Management of Non-Immune Effector Cell-Associated Neurotoxicity Syndrome Neurologic Events Following Ciltacabtagene Autoleucel in Multiple MyelomaDoris K Hansen, Omar Alexis Castaneda Puglianini, Ariel Grajales-Cruz, et al.
Current Medical Research and Opinion|April 30, 2026
Clinical outcomes with ciltacabtagene autoleucel among patients with relapsed/refractory multiple myeloma after four or more prior lines of therapy overall and among subgroups based on age, frailty, and CRAB symptomsDoris K Hansen, Omar Alexis Castaneda Puglianini, Ariel Grajales-Cruz, et al.
The Lancet. HIV|July 15, 2021
Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting studyRobin Schaefer, Heather-Marie A Schmidt, Giovanni Ravasi, et al.
European Journal of Haematology|December 28, 2020
Comorbidities and complications in adults with pyruvate kinase deficiencyAudra N Boscoe, Yan Yan, Elizabeth Hedgeman, et al.
Pediatric Blood & Cancer|June 14, 2021
Pyruvate kinase deficiency in childrenSatheesh Chonat, Stefan W Eber, Susanne Holzhauer, et al.
Plos One|May 4, 2022
Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021)Melanie M Taylor, Teodora Wi, Antonio Gerbase, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
American Journal of Hematology|May 19, 2020
Laboratory misdiagnosis of von Willebrand disease in post-menarchal females: A multi-center studyJulie Jaffray, Janice M Staber, Jemily Malvar, et al.
Blood|August 19, 2011
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971Alan S Gamis, Todd A Alonzo, Robert B Gerbing, et al.
Stroke|April 23, 2019
Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke ManagementKristin P Guilliams, Fenella J Kirkham, Susanne Holzhauer, et al.
Blood Advances|September 1, 2021
Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiencyHanny Al-Samkari, Eduard J van Beers, D Holmes Morton, et al.
Clinical Epidemiology|June 2, 2026
Real-World Incidence and Management of Non-Immune Effector Cell-Associated Neurotoxicity Syndrome Neurologic Events Following Ciltacabtagene Autoleucel in Multiple MyelomaDoris K Hansen, Omar Alexis Castaneda Puglianini, Ariel Grajales-Cruz, et al.
Current Medical Research and Opinion|April 30, 2026
Clinical outcomes with ciltacabtagene autoleucel among patients with relapsed/refractory multiple myeloma after four or more prior lines of therapy overall and among subgroups based on age, frailty, and CRAB symptomsDoris K Hansen, Omar Alexis Castaneda Puglianini, Ariel Grajales-Cruz, et al.
The Lancet. HIV|July 15, 2021
Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting studyRobin Schaefer, Heather-Marie A Schmidt, Giovanni Ravasi, et al.
European Journal of Haematology|December 28, 2020
Comorbidities and complications in adults with pyruvate kinase deficiencyAudra N Boscoe, Yan Yan, Elizabeth Hedgeman, et al.
Pediatric Blood & Cancer|June 14, 2021
Pyruvate kinase deficiency in childrenSatheesh Chonat, Stefan W Eber, Susanne Holzhauer, et al.
Plos One|May 4, 2022
Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021)Melanie M Taylor, Teodora Wi, Antonio Gerbase, et al.
Pageof 11